comparemela.com

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives $21.50 Average Price Target from Analysts

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives $21.50 Average Price Target from Analysts

theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada ,Steven Pfanstiel ,Scott Braunstein ,Robertw Baird ,Insider Transactions At Marinus Pharmaceuticals ,Marinus Pharmaceuticals Stock Performance ,Mirabella Financial Services ,Institutional Investors Weigh In On Marinus Pharmaceuticals ,Opaleye Management Inc ,News Ratings For Marinus Pharmaceuticals Daily ,Asset Management Inc ,Marinus Pharmaceuticals ,Denali Advisors ,Marinus Pharmaceuticals Inc ,Capital Corp ,Analyst Recommendations For Marinus Pharmaceuticals ,Royal Bank ,Nasdaq ,Get Free Report ,Asset Management ,Financial Services ,Get Free ,Marinus Pharmaceuticals Daily ,

comparemela.com © 2020. All Rights Reserved.